For Rogers, this year has been filled with pain and triumph, a year of repetitive setbacks and remarkable progress. In August 2017, Rogers was paralyzed by a rare autoimmune condition, known as CIDP. Her first steps — at first with the assist of a harness — came a month later. Read more in Chicago Tribune….Read More about CIDP Patient, Lynn Rogers, Running in Chicago Marathon!
LIVE PROGRAM Designed for healthcare professionals. Earn AMA PRA Category 1 Credit™. Date: Tuesday, September 25, 2018 Time: 12:00 PM – 1:00 PM EST Join our experts for a one-hour, live webinar as they discuss how to manage patients with immune-mediated neuropathies such as GBS and CIDP. Learning Objectives Recognize signs and symptoms that may suggest…Read More about Improving the Recognition of GBS and CIDP in the Hospital Setting: Live Program
David Saperstein, MD Co-Director GBS/CIDP Center of Excellence Phoenix Neurological Associates Phoenix, AZ Intravenous immunoglobulin (IVIg) is one of the main therapies used to treat CIDP. This therapy can be very effective but there are drawbacks. Some people experience headaches related to the intravenous infusions. Some people have difficulty with IV access. Also, the need…Read More about Subcutaneous Immunoglobulin: A Newly Approved Treatment Option for CIDP
Dr. Ken Gorson, Chairman of GBS|CIDP Foundation’s Global Medical Advisory Board, featured on LiveScience.com this week: Guillain-Barre Syndrome: Causes, Symptoms & Treatments. Read the full articleRead More about Dr. Ken Gorson Discusses GBS on LiveScience.com
We are happy to announce that Dr. Julie Rowin will be joining our prestigious line-up of speakers for our 2018 Symposium! Dr. Rowin is Board Certified in Neurology and Neuromuscular Medicine from the American Board of Psychiatry and Neurology. She also holds diplomate status with the American Board of Integrative and Holistic Medicine. She is…Read More about 2018 Symposium – NEW SESSION!